首页> 外国专利> sFlt-1/PlGF /PlGF MEANS AND METHODS APPLYING sFlt-1/PlGF OR ENDOGLIN/PlGF RATIO TO RULE-OUT ONSET OF PREECLAMPSIA WITHIN A CERTAIN TIME PERIOD

sFlt-1/PlGF /PlGF MEANS AND METHODS APPLYING sFlt-1/PlGF OR ENDOGLIN/PlGF RATIO TO RULE-OUT ONSET OF PREECLAMPSIA WITHIN A CERTAIN TIME PERIOD

机译:sFlt-1 / PlGF / PlGF手段和方法,在一定时期内应用sFlt-1 / PlGF或内皮糖蛋白/ PlGF比率来排除小儿癫痫的发作

摘要

The present invention relates to the field of diagnostic testing for prenatal diagnosis of toxemia. In particular, this relates to a method for diagnosing whether a pregnant subject is at risk for a pregnancy addiction in a short period of time, comprising the steps of: a) measuring the amount of one or more angiogenic indicators selected from the group consisting of sFlt-1, endoglin and PlGF in the sample of said subject, and b) comparing it with the reference amount, thereby diagnosing whether the subject is at risk of developing into a pregnancy addiction in a short period of time (for sFlt-1 and endoglin, if the amount is equal to or less than the reference amount, For the case of PlGF, the amount thereof is equal to or increased from the reference amount), the reference permitting diagnosis with a negative predictive value of about 98% or more. Also contemplated are an apparatus and kit for performing the method.
机译:本发明涉及产前诊断毒血症的诊断测试领域。特别地,这涉及一种用于诊断怀孕的对象是否在短时间内有怀孕成瘾风险的方法,其包括以下步骤:a)测量一种或多种选自以下组成的组的血管生成指示剂的量:所述受试者样品中的sFlt-1,内皮糖蛋白和PlGF,以及b)将其与参考量进行比较,从而诊断该受试者是否有在短时间内发展成妊娠成瘾的风险(对于sFlt-1和内皮糖蛋白,如果该量等于或小于参考量,对于PlGF,其量等于或比参考量增加),该参考允许诊断为阴性预测值约98%或更高。还考虑了用于执行该方法的设备和套件。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号